Literature DB >> 10632901

3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.

J C Vis1, M M Verbeek, R M De Waal, H J Ten Donkelaar, H P Kremer.   

Abstract

Systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP) to rats results in selective striatal lesions and serves as an experimental model of Huntington's disease (HD). However, the effects of the 3-NP treatment are unpredictable and result in lesions of variable severity. The present study was aimed at further characterizing the variability of the striatal lesions induced by systemic administration of 3-NP using osmotic pumps. Hematoxylin-eosin (HE) and Nissl stains as well as immunohistochemical labelling of astrocytes and striatal neurones were performed to analyse the neurotoxic effects of 3-NP. In general, chronic systemic administration of 3-NP resulted in obvious bilateral striatal lesions, which ranged from mild to severe, together with a subtle, but detectable behavioural lesion. Severe type lesions showed marked neuronal loss and an increased expression of glial fibrillary acidic protein (GFAP) in astrocytes surrounding the lesion area, whereas in the core of the lesion GFAP-immunoreactivity was absent. The mild type lesion was characterized by a substantial loss of striatal neurones and an increased expression of GFAP-positive astrocytes throughout the lesion. In a number of 3-NP-treated animals, neither type of lesion was observed, although these animals demonstrated behavioural changes in the paw test compared to controls. In the striatum of these tested 3-NP-treated animals, compromised rk' neurones were detected, suggestive of subtle and early 3-NP-induced neuronal injury. Similar dark neurones were also detected in mild and severe lesions and were immunocytochemically characterized as gamma-aminobutyric acid (GABA) and substance P containing spiny neurones, which belong to the neuronal population that is affected in early HD. These results indicate that systemic administration of 3-NP to rats may result in a spectrum of striatal pathology of which the morphology of the mild type lesion resembles the characteristic HD neuropathology most closely.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10632901     DOI: 10.1046/j.1365-2990.1999.00212.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  18 in total

1.  Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.

Authors:  Sarumani Natarajan Suganya; Thangarajan Sumathi
Journal:  Metab Brain Dis       Date:  2016-12-08       Impact factor: 3.584

2.  The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

Authors:  David Blum; David Gall; Marie-Christine Galas; Pablo d'Alcantara; Kadiombo Bantubungi; Serge N Schiffmann
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.

Authors:  Akram Sidhu; Vishal Diwan; Harsimran Kaur; Deepak Bhateja; Charan K Singh; Saurabh Sharma; Satyanarayana S V Padi
Journal:  Metab Brain Dis       Date:  2018-07-27       Impact factor: 3.584

4.  Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.

Authors:  Lamiaa A Ahmed; Hebatallah A Darwish; Rania M Abdelsalam; HebatAllah A Amin
Journal:  Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.590

5.  Concentrations of different sterols in the striatum and serum of 3-nitropropionic acid-treated Wistar and Lewis rats.

Authors:  C E Teunissen; M Mulder; J de Vente; K von Bergmann; C De Bruijn; H W Steinbusch; D Lütjohann
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

6.  Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats.

Authors:  Sara A Wahdan; Mariane G Tadros; Amani E Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-23       Impact factor: 3.000

7.  Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.

Authors:  T M Tsang; J N Haselden; E Holmes
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

Review 8.  Primary cultures of astrocytes: their value in understanding astrocytes in health and disease.

Authors:  Sofie C Lange; Lasse K Bak; Helle S Waagepetersen; Arne Schousboe; Michael D Norenberg
Journal:  Neurochem Res       Date:  2012-08-28       Impact factor: 3.996

9.  Puerarin ameliorates 3-nitropropionic acid-induced neurotoxicity in rats: possible neuromodulation and antioxidant mechanisms.

Authors:  Heba M Mahdy; Mohamed R Mohamed; Manal A Emam; Amr M Karim; Ashraf B Abdel-Naim; Amani E Khalifa
Journal:  Neurochem Res       Date:  2013-12-18       Impact factor: 3.996

10.  Characteristic Changes of Astrocyte and Microglia in Rat Striatum Induced by 3-NP and MCAO.

Authors:  Shuhua Mu; Bingbing Liu; Lisi Ouyang; Mali Zhan; Si Chen; Jiajia Wu; Jiachang Chen; Xianyou Wei; Weiping Wang; Jian Zhang; Wanlong Lei
Journal:  Neurochem Res       Date:  2015-11-19       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.